Document:

Exhibit 10.8

 

Execution Version

 

WARRANT

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER
ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED
UNLESS (A) A REGISTRATION STATEMENT COVERING THIS WARRANT OR SUCH SECURITIES, AS THE CASE MAY BE, IS EFFECTIVE UNDER THE ACT AND
IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (B) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS,
AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

 

Warrant Certificate No.: GCEH-027

 

Original Issue Date: August 5, 2022

 

FOR VALUE RECEIVED, GLOBAL CLEAN ENERGY HOLDINGS INC.,
a Delaware corporation (the “Company”), hereby certifies that ExxonMobil Renewables LLC, a Delaware limited
liability company (the “Holder”) is entitled to purchase from the Company 2,489,643 duly authorized, validly
issued, fully paid and nonassessable shares of Common Stock at a purchase price per share equal to $2.25 (subject to adjustment
as provided herein) (the “Exercise Price”), subject to the terms, conditions and adjustments set forth below
in this Warrant. Certain capitalized terms used herein are defined in Section 1.

 

1.           Definitions.
As used in this Warrant, the following terms have the respective meanings set forth below:

 

“Affiliate”
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by,
or is under common control with, such Person. The term “control” (including the terms “controlled by” and
“under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Aggregate Exercise
Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is then
being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price, in accordance with the terms
of this Warrant.

 

“Amendment No. 9
to Credit Agreement” means that certain Amendment No. 9 to the Credit Agreement, dated August 5, 2022, by and among BKRF
OCB, LLC, a Delaware limited liability company, BKRF OCP, LLC, a Delaware limited liability company, Bakersfield Renewable Fuels,
LLC, a Delaware limited liability company, and Orion Energy Partners TP Agent, LLC, as the administrative agent and collateral
agent.

 

    	 	 	 

     

    

 

“Board”
means the board of directors of the Company.

 

“Business Day”
means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of New York, New York are
authorized or obligated by law or executive order to close.

 

“Camelina”
means camelina, regardless of form (whether seed, grain or oil), developed, cultivated, produced, owned, and sold, by or on behalf
of, the Company or an Affiliate of the Company.

 

“Common Stock”
means the common stock, par value $0.01 per share, of the Company, and any capital stock into which such Common Stock shall have
been converted, exchanged or reclassified following the date hereof.

 

“Company”
has the meaning set forth in the preamble.

 

“Convertible Securities”
means any securities (directly or indirectly) exercisable for, convertible into or exchangeable for Common Stock, but excluding
Options.

 

“Excluded Issuances”
means any issuance or sale by the Company after the Original Issue Date of (a) shares of Common Stock issued upon the exercise
of this Warrant, (b) Common Stock (or Options with respect thereto) issued or issuable to employees or directors of, or consultants
to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the
Company, (c) shares of Common Stock issued or issuable pursuant to the terms of securities (including Convertible Securities) issued
under the Purchase Agreement, Amendment No. 9 to Credit Agreement or the Transaction Agreement (as such securities have been amended),
(d) securities issuable upon the exercise, exchange, or conversion of any Convertible Securities that are issued and outstanding
on the Original Issue Date, provided that such securities are not amended after the date hereof to increase the number of
shares of Common Stock issuable thereunder or to lower the exercise or conversion price thereof or (e) Common Stock, Options or
Convertible Securities with respect thereto, issued as acquisition consideration pursuant to the acquisition of another entity
by the Company by merger, purchase of substantially all of the assets or other reorganization or pursuant to a joint venture agreement.
In addition, for the avoidance of doubt, “Excluded Issuances” also include the filing of any registration statement
of the Company with the Securities and Exchange Commission registering securities of the Company, or the filing of any amendments
or supplements thereto, provided that the determination of whether any sale under any such registration statement is an
Excluded Issuance will be determined based on the preceding clauses (a) to (e) hereof.

 

“Exercise Agreement”
has the meaning set forth in Section 3(a)(i).

 

    	 	2	 

     

    

 

“Exercise Date”
means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in Section 3
shall have been satisfied at or prior to 5:00 p.m., New York, New York time, on a Business Day, including, without limitation,
the receipt by the Company of the Exercise Agreement, the Warrant and the Aggregate Exercise Price.

 

“Exercise Period”
has the meaning set forth in Section 2.

 

“Exercise Price”
has the meaning set forth in the preamble.

 

“Fair Market Value”
means, as of any particular date: (a) the volume weighted average of the closing sales prices of the Common Stock for such day
on all domestic securities exchanges on which the Common Stock may at the time be listed; (b) if there have been no sales of the
Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock
on all such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a domestic securities exchange,
the closing sales price of the Common Stock as quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system
or association for such day; or (d) if there have been no sales of the Common Stock on the OTC Bulletin Board, the Pink OTC Markets
or similar quotation system or association on such day, the average of the highest bid and lowest asked prices for the Common Stock
quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association at the end of such day; in each
case, averaged over three (3) consecutive Business Days ending on the Business Day immediately prior to the day as of which “Fair
Market Value” is being determined; provided, that if the Common Stock is listed on any domestic securities exchange,
the term “Business Day” as used in this sentence means Business Days on which such exchange is open for trading. If
at any time the Common Stock is not listed on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC
Markets or similar quotation system or association, the “Fair Market Value” of the Common Stock shall be the fair market
value per share as determined jointly by the Board and the Holder, or, if that selection cannot be made within ten (10) days, by
a nationally recognized and independent investment banking or valuation firm selected jointly and approved by the Board and the
Holder (including the methodologies to be utilized), or if joint selection and approval is not achieved within ten (10) days, the
American Arbitration Association shall select the independent investment banking or valuation firm in accordance with its rules.
The determination of such firm shall be final and conclusive, and the fees and expenses of such firm shall be borne equally by
the Company and the Holder.

 

“Holder”
has the meaning set forth in the preamble.

 

“Options”
means any warrants or other rights or options to subscribe for, or for the purchase of Common Stock or Convertible Securities.

 

“Original Issue
Date” means the date hereof.

 

    	 	3	 

     

    

 

“OTC Bulletin Board”
means the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-dealer quotation system.

 

“Person”
means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated
organization or government or department or agency thereof.

 

“Pink OTC Markets”
means the OTC Markets Group Inc. electronic inter-dealer quotation system, including OTCQX, OTCQB and OTC Pink.

 

“Purchase Agreement”
means that certain Securities Purchase Agreement, dated as of February 2, 2022, by and between the Company and the other parties
thereto.

 

“Purchase Rights”
has the meaning set forth in Section 5.

 

“Securities Act”
has the meaning set forth in Section 10(a).

 

“Transaction Agreement”
means the Transaction Agreement, dated as of August 5, 2022, by and among ExxonMobil Oil Corporation, Holder and the Company.

 

“Underlying Consideration”
has the meaning set forth in Section 4(b).

 

“Warrant”
means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.

 

“Warrant Shares”
means the shares of Common Stock of the Company then purchasable upon exercise of this Warrant in accordance with the terms of
this Warrant.

 

2.           Term
of Warrant. Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date
and prior to 5:00 p.m., New York, New York time, on December 23, 2028 or, if such day is not a Business Day, on the next preceding
Business Day (the “Exercise Period”), the Holder of this Warrant may exercise this Warrant for all or any part
of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).

 

		3.	Exercise of Warrant. 

 

(a)           Exercise
Procedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part
of the unexercised Warrant Shares, upon:

 

(i)           delivery
of an Exercise Agreement substantially in the form attached hereto as Exhibit A (each, an “Exercise Agreement”),
duly completed (including specifying the number of Warrant Shares to be purchased) and executed; and

 

(ii)           payment
to the Company of the Aggregate Exercise Price in accordance with Section 3(b).

 

    	 	4	 

     

    

 

Notwithstanding anything
to the contrary contained herein, the Holder shall not be required to deliver this Warrant in order to effect an exercise hereunder;
provided, however, that execution and delivery of the Exercise Agreement for the total amount of Common Stock available
to the Holder hereunder shall have the same effect as cancellation of this Warrant. Notwithstanding the foregoing, the Holder shall
deliver this Warrant in the event the right to acquire Warrant Shares pursuant to this Warrant has expired or has been fully exercised.

 

(b)          Payment
of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed
in the Exercise Agreement, by the following methods: 

 

(i)           by
delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately
available funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise Price;

 

(ii)           by
instructing the Company to withhold a number of Warrant Shares then issuable upon exercise of this Warrant with an aggregate Fair
Market Value as of the Exercise Date equal to such Aggregate Exercise Price;

 

(iii)           by
surrendering to the Company the Warrant Shares previously acquired by the Holder with an aggregate Fair Market Value as of the
Exercise Date equal to such Aggregate Exercise Price; or

 

(iv)           any
combination of the foregoing.

 

In the event of any withholding
of Warrant Shares or surrender of other equity securities pursuant to clause (ii), (iii) or (iv) above where the number of shares
whose value is equal to the Aggregate Exercise Price is not a whole number, the number of shares withheld by or surrendered to
the Company shall be rounded up to the nearest whole share and the Company shall make a cash payment to the Holder (by delivery
of a certified or official bank check or by wire transfer of immediately available funds) based on the incremental fraction of
a share being so withheld by or surrendered to the Company in an amount equal to the product of (x) such incremental fraction of
a share being so withheld or surrendered multiplied by (y) in the case of Common Stock, the Fair Market Value per Warrant Share
as of the Exercise Date.

 

(c)           Use
of Proceeds. The Company shall use the net proceeds from the Aggregate Exercise Price received hereunder to fund the continued
development of biofuels projects in which Holder or its Affiliates participate and the production of Camelina.

 

    	 	5	 

     

    

 

(d)           Delivery
of Stock Certificates. Upon receipt by the Company of the Exercise Agreement, surrender of this Warrant and payment of the
Aggregate Exercise Price (in accordance with Section 3(a)), the Company shall, as promptly as practicable, and in any event
within ten (10) Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder
a certificate or certificates representing the Warrant Shares issuable upon such exercise, together with cash in lieu of any fraction
of a share, as provided in Section 3(e). The stock certificate or certificates so delivered shall be, to the extent possible,
in such denomination or denominations as the exercising Holder shall reasonably request in the Exercise Agreement and shall be
registered in the name of the Holder or, subject to compliance with Section 6, such other Person’s name as shall be
designated in the Exercise Agreement. This Warrant shall be deemed to have been exercised and such certificate or certificates
of Warrant Shares shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall
be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the Exercise Date. Notwithstanding anything
to the contrary in this Section 3(d), the Warrant Shares may be issued in uncertificated or book-entry form, at the option
of the Holder, with such uncertificated Warrant Shares being evidenced by a book position either on the Company’s share register
or on the books of The Depository Trust Company, at the option of the Holder.

 

(e)           Fractional
Shares. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any fraction
of a Warrant Share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay to such Holder
an amount in cash (by delivery of a certified or official bank check or by wire transfer of immediately available funds) equal
to the product of (i) such fraction multiplied by (ii) the Fair Market Value of one Warrant Share on the Exercise Date.

 

(f)           Delivery
of New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised,
the Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in accordance
with Section 3(d), deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and
unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

 

(g)           Valid
Issuance of Warrant and Warrant Shares; Payment of Taxes. With respect to the exercise of this Warrant, the Company hereby
represents, covenants and agrees:

 

(i)           This
Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized
and validly issued.

 

(ii)           All
Warrant Shares issuable upon the exercise of this Warrant pursuant to the terms hereof shall be, upon issuance, and the Company
shall take all such actions as may be necessary or appropriate in order that such Warrant Shares are, validly issued, fully paid
and non-assessable, issued without violation of any preemptive or similar rights of any stockholder of the Company and free and
clear of all taxes, liens and charges.

 

    	 	6	 

     

    

 

(iii)           The
Company shall take all such actions as may be necessary to ensure that all such Warrant Shares are issued without violation by
the Company of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which
shares of Common Stock or other securities constituting Warrant Shares may be listed at the time of such exercise (except for official
notice of issuance which shall be immediately delivered by the Company upon each such issuance).

 

(iv)           The
Company shall use its best efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on any domestic securities
exchange upon which shares of Common Stock or other securities constituting Warrant Shares are listed at the time of such exercise.

 

(v)           The
Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be imposed with respect
to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required
to pay any tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery
of the Warrant Shares to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the
Person requesting such issuance has paid to the Company the amount of any such tax, or has established to the satisfaction of the
Company that such tax has been paid.

 

(h)           Conditional
Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection
with a public offering or a sale of the Company (pursuant to a merger, sale of stock, or otherwise), such exercise may at the election
of the Holder be conditioned upon the consummation of such transaction, in which case such exercise shall not be deemed to be effective
until immediately prior to the consummation of such transaction.

 

(i)           Reservation
of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but
unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of
this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and the par value per Warrant Share
shall at all times be less than or equal to the applicable Exercise Price. The Company shall not increase the par value of any
Warrant Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all such actions
as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares
of Common Stock upon the exercise of this Warrant.

 

4.           Adjustment
to Exercise Price and Warrant Shares. The Exercise Price and the number of Warrant Shares issuable upon exercise
of this Warrant shall be subject to adjustment from time to time as provided in this Section 4 (in each case, after taking
into consideration any prior adjustments pursuant to this Section 4).

 

    	 	7	 

     

    

 

(a)           Adjustment
to Exercise Price and Warrant Shares Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall, at any
time or from time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Common Stock
or any other capital stock of the Company payable in shares of Common Stock or in Options or Convertible Securities, or (ii) subdivide
(by any stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the
Exercise Price in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately reduced and
the number of Warrant Shares issuable upon exercise of this Warrant Certificate shall be proportionately increased. If the Company
at any time combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number
of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the number
of Warrant Shares issuable upon exercise of this Warrant Certificate shall be proportionately decreased. Any adjustment under this
Section 4(a) shall become effective at the close of business on the date the dividend, subdivision or combination becomes
effective. 

  

(b)           Adjustment
to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i)
capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from
par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination
of shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of
the Company’s assets to another Person or (v) other similar transaction, in each case which entitles the holders of Common
Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for
Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger, sale or similar
transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of Warrant Shares
then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or assets of
the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such reorganization,
reclassification, consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant in full immediately
prior to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction and acquired the
applicable number of Warrant Shares then issuable hereunder as a result of such exercise (without taking into account any limitations
or restrictions on the exercisability of this Warrant) (collectively, the “Underlying Consideration”); and,
in such case, appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the Holder’s
rights under this Warrant to insure that the provisions of this Section 4 shall thereafter be applicable, as nearly as possible,
to this Warrant in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Warrant (including,
in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing Person is other than
the Company, an immediate adjustment in the Exercise Price to the value per share for the Common Stock reflected by the terms of
such consolidation, merger, sale or similar transaction, and a corresponding immediate adjustment to the number of Warrant Shares
acquirable upon exercise of this Warrant without regard to any limitations or restrictions on exercise, if the value so reflected
is less than the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar transaction). If any
such reorganization, reclassification, consolidation, merger, sale or similar transaction entitles the holders of Common Stock
to receive more than a single type of consideration (determined based in part upon any form of stockholder election), then for
purposes of this Section 4(b), such consideration shall be deemed to be the weighted average of the types and amounts of
consideration actually received by the holders of Common Stock in such transaction. If, immediately after giving effect to any
such reorganization, reclassification, consolidation, merger, sale or similar transaction, shares of common stock that are listed
on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or any similar quotation system or
association account for less than 90% of the aggregate Fair Market Value of the Underlying Consideration (assuming the Fair Market
Value of any cash is the face amount of such cash), then the Exercise Price and the amount of the Underlying Consideration shall
be adjusted as of the effective date of such transaction to compensate the Holder for lost time value. Such adjustments shall be
determined based on a Black-Scholes option pricing model by a nationally recognized and independent investment banking or valuation
firm selected jointly and approved by the Board and the Holder; provided that (x) if such joint selection and approval is
not achieved within ten (10) days, the American Arbitration Association shall select the independent investment banking or valuation
firm in accordance with its rules and (y) the determination of such firm shall be final and conclusive, and the fees and expenses
of such firm shall be borne equally by the Company and the Holder. The provisions of this Section 4(b) shall similarly apply
to successive reorganizations, reclassifications, consolidations, mergers, sales or similar transactions. The Company shall not
effect any such reorganization, reclassification, consolidation, merger, sale or similar transaction unless, prior to the consummation
thereof, the successor Person (if other than the Company) resulting from such reorganization, reclassification, consolidation,
merger, sale or similar transaction, shall assume, by written instrument substantially similar in form and substance to this Warrant
and satisfactory to the Holder, the obligation to deliver to the Holder such shares of stock, securities or assets which, in accordance
with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant. Notwithstanding anything
to the contrary contained herein, with respect to any corporate event or other transaction contemplated by the provisions of this
Section 4(b), the Holder shall have the right to receive the same consideration as any other holder of Common Stock if the
Holder elects prior to the consummation of such event or transaction to give effect to the exercise rights contained in Section
2 instead of giving effect to the provisions contained in this Section 4(b) with respect to this Warrant.

 

(c)           Certain
Events. If any event of the type contemplated by the provisions of this Section 4 but not expressly provided for by
such provisions (including, without limitation, a premium self-tender offer, a dividend or distribution upon the Common Stock payable
in cash or other assets or property, or the granting of stock appreciation rights, phantom stock rights or other rights with equity
features, other than with respect to any Excluded Issuance) occurs, then the Board shall make an appropriate adjustment in the
Exercise Price and the number of Warrant Shares issuable upon exercise of this Warrant so as to protect the rights of the Holder
in a manner consistent with the provisions of this Section 4; provided, that no such adjustment pursuant to this
Section 4(c) shall increase the Exercise Price or decrease the number of Warrant Shares issuable as otherwise determined
pursuant to this Section 4, and for the avoidance of doubt, no adjustment pursuant to this Section 4(c) shall be
made in connection with any Excluded Issuance. 

 

    	 	8	 

     

    

 

		(d)	Certificate as to Adjustment. 

 

(i)           As
promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than ten (10) Business
Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail
such adjustment and the facts upon which it is based and certifying the calculation thereof.

 

(ii)           As
promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not
later than ten (10) Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying
the Exercise Price then in effect and the number of Warrant Shares or the amount, if any, of other shares of stock, securities
or assets then issuable upon exercise of the Warrant. 

 

		(e)	Notices. In the event:

 

(i)           that
the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon
exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to vote at
a meeting (or by written consent), to receive any right to subscribe for or purchase any shares of capital stock of any class or
any other securities, or to receive any other security; or

 

(ii)           of
any capital reorganization of the Company, any reclassification of the Common Stock of the Company, any consolidation or merger
of the Company with or into another Person, or sale of all or substantially all of the Company’s assets to another Person;
or 

 

(iii)           of
the voluntary or involuntary dissolution, liquidation or winding-up of the Company;

 

then, and in each such case,
the Company shall send or cause to be sent to the Holder at least thirty (30) days prior to the applicable record date or the applicable
expected effective date, as the case may be, for the event, a written notice specifying, as the case may be, (A) the record date
for such dividend, distribution, meeting or consent or other right or action, and a description of such dividend, distribution
or other right or action to be taken at such meeting or by written consent, or (B) the effective date on which such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up is proposed to take place, and the date,
if any is to be fixed, as of which the books of the Company shall close or a record shall be taken with respect to which the holders
of record of Common Stock (or such other capital stock or securities at the time issuable upon exercise of the Warrant) shall be
entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property
deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, and
the amount per share and character of such exchange applicable to the Warrant and the Warrant Shares.

 

    	 	9	 

     

    

 

5.           Purchase
Rights. If at any time the Company grants, issues or sells any shares of Common Stock or rights to purchase stock, warrants,
securities or other property pro rata to the record holders of Common Stock (the “Purchase Rights”),
then the Holder shall be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights
which the Holder would have acquired if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this
Warrant immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if
no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights. Anything herein to the contrary notwithstanding, the Holder shall not be entitled to the Purchase Rights
granted herein with respect to any Excluded Issuance.

 

6.           Transfer
of Warrant. This Warrant and all rights hereunder are transferable, in whole or in part, by the Holder without charge
to the Holder or consent of the Company, upon surrender of this Warrant to the Company at its then principal executive offices
with a properly completed and duly executed assignment agreement substantially in the form attached hereto as Exhibit B,
together with funds sufficient to pay any transfer taxes described in Section 3(g)(v) in connection with the making of such
transfer. Upon such compliance, surrender and delivery and, if required, such payment, the Company shall execute and deliver a
new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant
shall promptly be cancelled.

 

7.           Holder
Not Deemed a Stockholder; Limitations on Liability. Except as otherwise specifically provided herein, prior to the issuance
to the Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the
Holder shall not be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for
any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of
a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization,
issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive
dividends or subscription rights, or otherwise. In addition, nothing contained in this Warrant shall be construed as imposing any
liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company,
whether such liabilities are asserted by the Company or by creditors of the Company.

 

    	 	10	 

     

    

 

		8.	Replacement on Loss; Division and Combination.

 

(a)           Replacement
of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification
agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such
Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof,
a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated
or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable
form is surrendered to the Company for cancellation.

 

(b)           Division
and Combination of Warrant. This Warrant may be divided or, following any such division of this Warrant, subsequently combined
with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal executive offices, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the respective Holders
or their agents or attorneys. The Company shall at its own expense execute and deliver a new Warrant or Warrants in exchange for
the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or Warrants shall be of like tenor to the
surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number of Warrant Shares as the Warrant
or Warrants so surrendered in accordance with such notice. 

 

9.           No
Impairment. The Company shall not, by amendment of its Certificate of Incorporation or Bylaws, or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek
to avoid the observance or performance of any of the terms to be observed or performed by it hereunder, but shall at all times
in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably
be requested by the Holder in order to protect the exercise rights of the Holder against dilution or other impairment, consistent
with the tenor and purpose of this Warrant.

 

		10.	Compliance with the Securities Act.

 

(a)           Agreement
to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects with the
provisions of this Section 10 and the restrictive legend requirements set forth on the face of this Warrant and further
agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise
hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended (the “Securities
Act”). This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Securities
Act) shall be stamped or imprinted with a legend in substantially the following form:

 

    	 	11	 

     

    

 

“THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING THIS WARRANT OR SUCH SECURITIES, AS THE CASE MAY BE, IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND
PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF
THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

(b)          Representations
of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the Original Issue
Date, to the Company by acceptance of this Warrant as follows:

 

(i)           The
Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.
The Holder is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own account
and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares,
except pursuant to sales registered or exempted under the Securities Act. 

 

(ii)           The
Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving
a public offering and that, under such laws and applicable regulations, such securities may be resold without registration under
the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule 144
under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities
Act.

 

(iii)           The
Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge
and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the
Warrant and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company regarding
the terms and conditions of the offering of the Warrant and the business, properties, prospects and financial condition of the
Company.

 

    	 	12	 

     

    

 

11.           Warrant
Register. The Company shall keep and properly maintain at its principal executive offices books for the registration
of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on
such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except
any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions of this Warrant.

 

12.           Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed
to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document
(with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent
after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return
receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated below
(or at such other address for a party as shall be specified in a notice given in accordance with this Section 12).

 

	 If to the Company:	
        Global Clean Energy Holdings, Inc.

        2790 Skypark Drive, Suite 105

        Torrance, CA 90505

        Attention:

        Fax:

        Email:

         

	with a copy to:	
        King & Spalding LLP

        Attention:

        1100 Louisiana

        Suite 4100

        Houston, TX 77002

        Email:

         

	If to the Holder:	
        ExxonMobil Renewables LLC

         

        22777 Springwoods Village Parkway

        Spring, Texas 77389

        Attention:

        Email:

         

	With a copy to:	
        Davis Polk & Wardwell LLP

        450 Lexington Avenue

        New York, NY 10017

        Attention:

        Email:

         

 

    	 	13	 

     

    

 

13.           Cumulative
Remedies. Except to the extent expressly provided in Section 7 to the contrary, the rights and remedies provided
in this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or
remedies available at law, in equity or otherwise.

 

14.           Equitable
Relief. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its
obligations under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not
be an adequate remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations,
the other party hereto shall, in addition to any and all other rights and remedies that may be available to it in respect of such
breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance and any other relief
that may be available from a court of competent jurisdiction.

 

15.           Entire
Agreement. This Warrant constitutes the sole and entire agreement of the parties to this Warrant with respect to the
subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral,
with respect to such subject matter.

 

16.           Successor
and Assigns. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the
parties hereto and the successors of the Company and the successors and assigns of the Holder. Such successors and/or assigns of
the Holder shall be deemed to be a Holder for all purposes hereunder.

 

17.           No
Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors
and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any
other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.

 

18.           Headings.
The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.

 

19.           Amendment
and Modification; Waiver. Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented
by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof
shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate
or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether
of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising,
any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any
single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or
the exercise of any other right, remedy, power or privilege.

 

    	 	14	 

     

    

 

20.           Severability.
If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality
or unenforceability shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term
or provision in any other jurisdiction.

 

21.           Governing
Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of Delaware without
giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that
would cause the application of laws of any jurisdiction other than those of the State of Delaware.

 

22.           Submission
to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions
contemplated hereby may be instituted in the state courts of Delaware and to the jurisdiction of the United States District Court
for the District of Delaware, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit,
action or proceeding. Service of process, summons, notice or other document by certified or registered mail to such party’s
address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court.
The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in
such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought
in any such court has been brought in an inconvenient forum.

 

23.           Waiver
of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Warrant is likely
to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it
may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions contemplated
hereby.

 

24.           Counterparts.
This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed
to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.

 

25.           No
Strict Construction. This Warrant shall be construed without regard to any presumption or rule requiring construction
or interpretation against the party drafting an instrument or causing any instrument to be drafted.

 

[signature page
follows]

 

    	 	15	 

     

    

 

IN WITNESS WHEREOF, the Company has
duly executed this Warrant on the Original Issue Date.

 

	 	GLOBAL CLEAN ENERGY HOLDINGS, INC.	 
	 	 	 
	 	By: 	        	 
	 	Name:	 	 
	 	Title:	 	 

 

[Signature Page to GCEH Warrant]

 

    	 	 	 

     

    

 

	Accepted and agreed,	 
	 	 
	EXXONMOBIL RENEWABLES LLC	 
	 	 	 
	By: 	           	 
	Name:	 	 
	Title: 	 	 

 

[Signature Page to GCEH Warrant]

 

    	 	 	 

     

    

 

Exhibit A

 

NOTICE OF EXERCISE

 

TO:GLOBAL
CLEAN ENERGY HOLDINGS, INC.

 

(1)            The
undersigned hereby elects to purchase [ ] Warrant Shares of the Company pursuant to the terms of the attached Warrant and tenders
herewith payment of the Aggregate Exercise Price in full.

 

(2)            Payment
shall take the form of (check all applicable boxes):

 

 ̈
certified or official bank check payable to the order of the Company, or by wire
transfer of immediately available funds;

 

 ̈
cashless exercise pursuant to the cashless exercise procedure in Section 3(b)(ii);
or

 

 ̈ cashless
exercise pursuant to the cashless exercise procedure in Section 3(b)(iii).

 

(3)             Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

	 	 	 

 

[The Warrant Shares shall be delivered to the following
DWAC Account Number:]

 

	 	 	 

 

	 	 	 

 

	 	 	 

 

[NAME OF HOLDER]

 

	 	 
	Signature of Authorized Signatory of Holder:	 
	 	 
	Name of Authorized Signatory:	 
	 	 
	Title of Authorized Signatory:	 

 

	Date of Execution:	 	 

 

    	 	 	 

     

    

 

Exhibit B

 

Assignment and Assumption

 

Reference
is made to that certain (i) Warrant, dated as of August 5, 2022, represented by Warrant Certificate No. GCEH-[  ]
(the “Warrant”), issued by Global Clean Energy Holdings Inc., a
Delaware corporation (the “Company”) to [  ]
(the “Assignor”) [and (ii) Registration Rights Agreement, dated
February 23, 2022, by and among the Company, the Assignor and the other parties thereto (as amended, amended and restated, supplemented
or otherwise modified, the “Registration Rights Agreement”)]. Capitalized terms used herein but not otherwise
defined shall have the meanings ascribed to such terms in the Warrant [and the Registration Rights Agreement, as applicable].

 

FOR VALUE RECEIVED, the Assignor
hereby sells, assigns and transfers that portion of Assignor’s rights under the Warrant and the number of Warrant Shares
issuable pursuant thereto to the Assignee as follows:

 

	Name of Assignee	Address	Number of Warrant Shares
	[  ]	
        [  ]

        Attn: [  ]

        Email: []
	[  ]

 

[In addition, the Assignor hereby assigns and transfers
to the Assignee its rights, duties and obligations under the Registration Rights Agreement to the extent of Assignee’s interest
in the Warrant Shares set forth above (which for the avoidance of doubt are Registrable Securities under the Registration Rights
Agreement), and Assignee hereby accepts and assumes such rights, duties and obligations from the Assignor, including with respect
to its indemnification obligations under Section 7(b) of the Registration Rights Agreement. All notices to be given by the Company
to the Assignee as a Holder of the Warrant shall be sent to the Assignee at the above listed address.]

 

[In
accordance with Section 6 of the Warrant, the Assignor requests that the Company execute and deliver a new Warrant in the name
of the Assignee representing the number of Warrant Shares set forth above, and a new Warrant representing [  ]
Warrant Shares in the name of the Assignor.]

 

In addition to the making of the
representations and warranties set forth in Section 10(b) of the Warrant, the Assignee represents and warrants that the Assignee
is acquiring the Warrant and the Warrant Shares for its own account or the account of an Affiliate for investment purposes and
not with the view to any sale or distribution, and that the Assignee will not offer, sell or otherwise dispose of the Warrant or
the Warrant Shares except pursuant to the terms of the Warrant and under circumstances as will not result in a violation of applicable
securities laws.

 

[SIGNATURE PAGE FOLLOWS]

 

    	 	 	 

     

    

 

Dated Effective: [_______], 2022

 

	 	ASSIGNOR:	 
	 	 	 	 
	 	[  ]	 	 
	 	 	 	 
	 	By:	         	 
	 	Name:	 	 
	 	Title:	 	 

 

	 	ASSIGNEE:	 
	 	 	 	 
	 	[  ]	 	 
	 	 	 	 
	 	By: 	         	 
	 	Name:	 	 
	 	Title:	 	 

 

	ACKNOWLEDGED:	 	 
	 	 	 
	Global Clean Energy Holdings Inc.	 	 
	 	 	 	 
	By: 	                      	 	 
	Name:	 	 	 
	Title:Exhibit 10.9

 

Execution Version

 

OMNIBUS AMENDMENT TO WARRANT AGREEMENTS

 

This Omnibus Amendment (this “Amendment”)
to those certain Warrants (as defined below) is entered into as of August 5, 2022 (the “Effective Date”), by and among
Global Clean Energy Holdings, Inc., a Delaware corporation (the “Company”), Sustainable Oils, Inc., a Delaware corporation
and wholly-owned subsidiary of the Company (“SusOils”), and ExxonMobil Renewables LLC, a Delaware limited liability
company (the “Holder”). The Company, SusOils and the Holder are each referred to herein as a “Party”
and collectively as the “Parties”. Capitalized terms used but not otherwise defined have the meanings ascribed to such
terms in the Warrants.

 

WHEREAS, pursuant to that certain
Securities Purchase Agreement, dated as of February 2, 2022, by and between the Company, the Holder and the other parties thereto, on
February 23, 2022, the Company (i) issued to the Holder Warrant Certificate No. GCEH-001 providing for the purchase by the Holder of up
to 13,530,723 shares of the Company’s common stock at an exercise price of $2.25 per share (the “Tranche I Warrant”),
(ii) issued to the Holder Warrant Certificate No. GCEH II-001 providing for the purchase by the Holder of up to 6,500,000 shares of the
Company’s common stock at an exercise price of $3.75 per share (the “Tranche II Warrant”) and (iii) caused SusOils
to issue to the Holder Warrant Certificate No. SUSO-001 providing for the purchase by the Holder of up to 19,701,493 shares of SusOils’s
common stock at an exercise price of $1.675 per share (the “SusOils Warrant” and together with the Tranche I Warrant
and Tranche II Warrant, the “Warrants”); and

 

WHEREAS, pursuant to the terms
of that certain Transaction Agreement, by and between the Company, ExxonMobil Oil Corporation and the Holder, dated as of the date hereof
(the “Transaction Agreement”), the Company and the Holder desire to amend each of the Warrants to, among other things,
adjust the exercise prices and exercise period set forth therein.

 

NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by the Parties hereto, the Parties agree as follows:

 

1.     Amendments
to Tranche I Warrant. Effective as of the Effective Date, pursuant to Section 19 of the Tranche I Warrant, each Party hereby agrees
as follows:

 

		(a)	The following definitions are hereby added to Section 1:

 

“Amendment No.
9 to Credit Agreement” means that certain Amendment No. 9 to the Credit Agreement, dated August 5, 2022, by and among BKRF OCB,
LLC, a Delaware limited liability company, BKRF OCP, LLC, a Delaware limited liability company, Bakersfield Renewable Fuels, LLC, a Delaware
limited liability company, and Orion Energy Partners TP Agent, LLC, as the administrative agent and collateral agent.

 

“Transaction Agreement”
means the Transaction Agreement, dated as of August 5, 2022, by and among ExxonMobil Oil Corporation, Holder and the Company.

 

“Underlying Consideration”
has the meaning set forth in Section 4(b).

 

     

     

    

 

		(b)	The following definitions are hereby amended and restated as follows:

 

“Excluded Issuances”
means any issuance or sale by the Company after the Original Issue Date of (a) shares of Common Stock issued upon the exercise of this
Warrant, (b) Common Stock (or Options with respect thereto) issued or issuable to employees or directors of, or consultants to, the Company
or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Company, (c) shares
of Common Stock issued or issuable pursuant to the terms of securities (including Convertible Securities) issued under the Purchase Agreement,
Amendment No. 9 to Credit Agreement or the Transaction Agreement (as such securities have been amended), (d) securities issuable upon
the exercise, exchange, or conversion of any Convertible Securities that are issued and outstanding on the Original Issue Date, provided
that such securities are not amended after the date hereof to increase the number of shares of Common Stock issuable thereunder or to
lower the exercise or conversion price thereof or (e) Common Stock, Options or Convertible Securities with respect thereto, issued as
acquisition consideration pursuant to the acquisition of another entity by the Company by merger, purchase of substantially all of the
assets or other reorganization or pursuant to a joint venture agreement. In addition, for the avoidance of doubt, “Excluded Issuances”
also include the filing of any registration statement of the Company with the Securities and Exchange Commission registering securities
of the Company, or the filing of any amendments or supplements thereto, provided that the determination of whether any sale under
any such registration statement is an Excluded Issuance will be determined based on the preceding clauses (a) to (e) hereof.

 

“Fair Market
Value” means, as of any particular date: (a) the volume weighted average of the closing sales prices of the Common Stock
for such day on all domestic securities exchanges on which the Common Stock may at the time be listed; (b) if there have been no
sales of the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the
Common Stock on all such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a domestic
securities exchange, the closing sales price of the Common Stock as quoted on the OTC Bulletin Board, the Pink OTC Markets or
similar quotation system or association for such day; or (d) if there have been no sales of the Common Stock on the OTC Bulletin
Board, the Pink OTC Markets or similar quotation system or association on such day, the average of the highest bid and lowest asked
prices for the Common Stock quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association at the
end of such day; in each case, averaged over three (3) consecutive Business Days ending on the Business Day immediately prior to the
day as of which “Fair Market Value” is being determined; provided, that if the Common Stock is listed on any
domestic securities exchange, the term “Business Day” as used in this sentence means Business Days on which such
exchange is open for trading. If at any time the Common Stock is not listed on any domestic securities exchange or quoted on the OTC
Bulletin Board, the Pink OTC Markets or similar quotation system or association, the “Fair Market Value” of the Common
Stock shall be the fair market value per share as determined jointly by the Board and the Holder, or, if that selection cannot be
made within ten (10) days, by a nationally recognized and independent investment banking or valuation firm selected jointly and
approved by the Board and the Holder (including the methodologies to be utilized), or if joint selection and approval is not
achieved within ten (10) days, the American Arbitration Association shall select the independent investment banking or valuation
firm in accordance with its rules. The determination of such firm shall be final and conclusive, and the fees and expenses of such
firm shall be borne equally by the Company and the Holder.

 

    	 	2	 

     

    

 

		(c)	Section 2 is hereby amended and restated in its entirety as follows:

 

“2. Term of Warrant.
Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date and prior to 5:00 p.m., New
York, New York time, on December 23, 2028, or if such day is not a Business Day, on the next preceding Business Day (the “Exercise
Period”), the Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder
(subject to adjustment as provided herein).”

 

		(d)	The last sentence of Section 3(d) is hereby amended and restated as follows:

 

“Notwithstanding
anything to the contrary in this Section 3(d), the Warrant Shares may be issued in uncertificated or book-entry form, at the option
of the Holder, with such uncertificated Warrant Shares being evidenced by a book position either on the Company’s share register
or on the books of The Depository Trust Company, at the option of the Holder.”

 

    	 	3	 

     

    

 

		(e)	Section 4(b) is hereby amended and restated in its entirety as follows:

 

“Adjustment
to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i)
capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from
par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or
combination of shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially
all of the Company’s assets to another Person or (v) other similar transaction, in each case which entitles the holders of
Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange
for Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger, sale or
similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of
Warrant Shares then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or
assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon
such reorganization, reclassification, consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant
in full immediately prior to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction
and acquired the applicable number of Warrant Shares then issuable hereunder as a result of such exercise (without taking into
account any limitations or restrictions on the exercisability of this Warrant) (collectively, the “Underlying
Consideration”); and, in such case, appropriate adjustment (in form and substance satisfactory to the Holder) shall be
made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 4 shall
thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets thereafter
acquirable upon exercise of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction in which
the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share
for the Common Stock reflected by the terms of such consolidation, merger, sale or similar transaction, and a corresponding
immediate adjustment to the number of Warrant Shares acquirable upon exercise of this Warrant without regard to any limitations or
restrictions on exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such
consolidation, merger, sale or similar transaction). If any such reorganization, reclassification, consolidation, merger, sale or
similar transaction entitles the holders of Common Stock to receive more than a single type of consideration (determined based in
part upon any form of stockholder election), then for purposes of this Section 4(b), such consideration shall be deemed to be
the weighted average of the types and amounts of consideration actually received by the holders of Common Stock in such transaction.
If, immediately after giving effect to any such reorganization, reclassification, consolidation, merger, sale or similar
transaction, shares of common stock that are listed on any domestic securities exchange or quoted on the OTC Bulletin Board, the
Pink OTC Markets or any similar quotation system or association account for less than 90% of the aggregate Fair Market Value of the
Underlying Consideration (assuming the Fair Market Value of any cash is the face amount of such cash), then the Exercise Price and
the amount of the Underlying Consideration shall be adjusted as of the effective date of such transaction to compensate the Holder
for lost time value. Such adjustments shall be determined based on a Black-Scholes option pricing model by a nationally recognized
and independent investment banking or valuation firm selected jointly and approved by the Board and the Holder; provided that
(x) if such joint selection and approval is not achieved within ten (10) days, the American Arbitration Association shall select the
independent investment banking or valuation firm in accordance with its rules and (y) the determination of such firm shall be final
and conclusive, and the fees and expenses of such firm shall be borne equally by the Company and the Holder. The provisions of this Section
4(b) shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales or similar
transactions. The Company shall not effect any such reorganization, reclassification, consolidation, merger, sale or similar
transaction unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting from such
reorganization, reclassification, consolidation, merger, sale or similar transaction, shall assume, by written instrument
substantially similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder
such shares of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to
receive upon exercise of this Warrant. Notwithstanding anything to the contrary contained herein, with respect to any corporate
event or other transaction contemplated by the provisions of this Section 4(b), the Holder shall have the right to receive
the same consideration as any other holder of Common Stock if the Holder elects prior to the consummation of such event or
transaction to give effect to the exercise rights contained in Section 2 instead of giving effect to the provisions contained
in this Section 4(b) with respect to this Warrant.”

 

    	 	4	 

     

    

 

		(f)	Section 4(c) is hereby amended and restated as follows:

 

“Certain Events.
If any event of the type contemplated by the provisions of this Section 4 but not expressly provided for by such provisions (including,
without limitation, a premium self-tender offer, a dividend or distribution upon the Common Stock payable in cash or other assets or property,
or the granting of stock appreciation rights, phantom stock rights or other rights with equity features, other than with respect to any
Excluded Issuance) occurs, then the Board shall make an appropriate adjustment in the Exercise Price and the number of Warrant Shares
issuable upon exercise of this Warrant so as to protect the rights of the Holder in a manner consistent with the provisions of this Section
4; provided, that no such adjustment pursuant to this Section 4(c) shall increase the Exercise Price or decrease the
number of Warrant Shares issuable as otherwise determined pursuant to this Section 4, and for the avoidance of doubt, no adjustment
pursuant to this Section 4(c) shall be made in connection with any Excluded Issuance.”

 

		(g)	The legend set forth on the face of the Tranche I Warrant and in Section 10(a) is hereby amended and restated
as follows:

 

“THIS WARRANT AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING THIS WARRANT OR SUCH SECURITIES, AS THE CASE MAY BE, IS EFFECTIVE UNDER THE ACT
AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS,
AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

    	 	5	 

     

    

 

		(h)	The definition of “Holder” in the preamble is hereby changed from “Exxon Renewables
LLC” to “ExxonMobile Renewables LLC”.

 

2.    Amendments
to Tranche II Warrant. Effective as of the Effective Date, pursuant to Section 19 of the Tranche II Warrant, each Party hereby agrees
as follows:

 

		(a)	The “Exercise Price” of the Tranche II Warrant is hereby changed from $3.75 per share to $2.25
per share.

 

		(b)	Section 2 is hereby amended and restated in its entirety as follows:

 

“2. Term of Warrant.
Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date and prior to 5:00 p.m., New
York, New York time, on December 23, 2028, or if such day is not a Business Day, on the next preceding Business Day (the “Exercise
Period”), the Holder of this Warrant may exercise this Warrant for all or any part of the Vested Warrant Shares purchasable
hereunder (subject to adjustment as provided herein).”

 

		(c)	The amendments to the Tranche I Warrant set forth in Section 1(a), (b) and (d) through (g) of this Amendment
shall apply to the Tranche II Warrant, mutatis mutandis.

 

 3.    Amendments to SusOils Warrant. Effective as of the Effective Date, pursuant to Section 20 of the SusOils Warrant, each Party hereby agrees as follows:

 

		(a)	The “Exercise Price” of the SusOils Warrant is hereby changed from $1.675 per share to an
aggregate exercise price of $1,000,000, being approximately $0.0507575746 per share.

 

		(b)	The last sentence of the second paragraph of the SusOils Warrant (immediately prior to Section 1 and beginning
with “For purposes of this Warrant”) is hereby deleted in its entirety.

 

		(c)	Section 2 is hereby amended and restated in its entirety as follows:

 

“2. Term of Warrant.
“Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date and prior to 5:00 p.m.,
New York, New York time, on December 23, 2028, or if such day is not a Business Day, on the next preceding Business Day (the “Exercise
Period”), the Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder
(subject to adjustment as provided herein).”

 

    	 	6	 

     

    

 

		(d)	Section 4(b) is hereby amended and restated in its entirety as follows:

 

“Adjustment
to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i)
capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from
par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or
combination of shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially
all of the Company’s assets to another Person or (v) other similar transaction, in each case which entitles the holders of
Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange
for Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger, sale or
similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of
Warrant Shares then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or
assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon
such reorganization, reclassification, consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant
in full immediately prior to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction
and acquired the applicable number of Warrant Shares then issuable hereunder as a result of such exercise (without taking into
account any limitations or restrictions on the exercisability of this Warrant) (collectively, the “Underlying
Consideration”); and, in such case, appropriate adjustment (in form and substance satisfactory to the Holder) shall be
made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 4 shall
thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets thereafter
acquirable upon exercise of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction in which
the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share
for the Common Stock reflected by the terms of such consolidation, merger, sale or similar transaction, and a corresponding
immediate adjustment to the number of Warrant Shares acquirable upon exercise of this Warrant without regard to any limitations or
restrictions on exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such
consolidation, merger, sale or similar transaction). If any such reorganization, reclassification, consolidation, merger, sale or
similar transaction entitles the holders of Common Stock to receive more than a single type of consideration (determined based in
part upon any form of stockholder election), then for purposes of this Section 4(b), such consideration shall be deemed to be
the weighted average of the types and amounts of consideration actually received by the holders of Common Stock in such transaction.
To the extent the Warrant Shares are listed on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC
Markets or any similar quotation system or association and if, immediately after giving effect to any such reorganization,
reclassification, consolidation, merger, sale or similar transaction, shares of common stock that are listed on any domestic
securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or any similar quotation system or association account
for less than 90% of the aggregate Fair Market Value of the Underlying Consideration (assuming the Fair Market Value of any cash is
the face amount of such cash), then the Exercise Price and the amount of the Underlying Consideration shall be adjusted as of the
effective date of such transaction to compensate the Holder for lost time value. Such adjustments shall be determined based on a
Black-Scholes option pricing model by a nationally recognized and independent investment banking or valuation firm selected jointly
and approved by the Board and the Holder; provided that (x) if such joint selection and approval is not achieved within ten
(10) days, the American Arbitration Association shall select the independent investment banking or valuation firm in accordance with
its rules and (y) the determination of such firm shall be final and conclusive, and the fees and expenses of such firm shall be
borne equally by the Company and the Holder. The provisions of this Section 4(b) shall similarly apply to successive
reorganizations, reclassifications, consolidations, mergers, sales or similar transactions. The Company shall not effect any such
reorganization, reclassification, consolidation, merger, sale or similar transaction unless, prior to the consummation thereof, the
successor Person (if other than the Company) resulting from such reorganization, reclassification, consolidation, merger, sale or
similar transaction, shall assume, by written instrument substantially similar in form and substance to this Warrant and
satisfactory to the Holder, the obligation to deliver to the Holder such shares of stock, securities or assets which, in accordance
with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant. Notwithstanding anything to
the contrary contained herein, with respect to any corporate event or other transaction contemplated by the provisions of this Section
4(b), the Holder shall have the right to receive the same consideration as any other holder of Common Stock if the Holder elects
prior to the consummation of such event or transaction to give effect to the exercise rights contained in Section 2 instead
of giving effect to the provisions contained in this Section 4(b) with respect to this Warrant.”

  

		(e)	The amendments to the Tranche I Warrant set forth in Section 1(a), (b), (f) and (g) of this Amendment
shall apply to the SusOils Warrant, mutatis mutandis.

 

    	 	7	 

     

    

 

4.       References
to Warrants. After giving effect to this Amendment, each reference in each applicable Warrant to “this Warrant”, “hereof”,
“hereunder”, “herein” or words or phrases of similar import shall refer to such Warrant, as amended by this Amendment.

 

5.       Entire
Agreement. This Amendment, together with the Transaction Agreement and each Warrant constitutes the entire agreement among the Company,
SusOils and the Holder with respect to the subject matter hereof and thereof and supersedes any prior understandings, negotiations, agreements,
statements or representations among the Holder, the Company, SusOils or any of their respective Affiliates of any nature, whether written
or oral, to the extent they relate in any way to the subject matter hereof or thereof.

 

6.       No
Other Amendments. Except as expressly amended by this Amendment, the terms of each Warrant shall remain in full force and effect.

 

7.       Miscellaneous
Terms. The provisions of Sections 18 (Headings), 19 (Amendment and Modification; Waiver), 20 (Severability), 21 (Governing Law), 22
(Submission to Jurisdiction), 23 (Waiver of Jury Trial), 24 (Counterparts) and 25 (No Strict Construction) of the Tranche I Warrant and
Tranche II Warrant, and Sections 19 (Headings), 20 (Amendment and Modification; Waiver), 21 (Severability), 22 (Governing Law), 23 (Submission
to Jurisdiction), 24 (Waiver of Jury Trial), 25 (Counterparts) and 26 (No Strict Construction) of the SusOils Warrant shall apply mutatis
mutandis to this Amendment.

 

[Signature page follows]

 

    	 	8	 

     

    

 

IN WITNESS WHEREOF, each Party
has executed this Amendment effective as of the Effective Date.

 

	 	GLOBAL CLEAN ENERGY HOLDINGS, INC.
	 	 	 
	 	By: 	 
	 	 	Name: Richard Palmer
	 	 	Title:   Chief Executive Officer
	 	 	 
	 	SUSTAINABLE OILS, INC.
	 	 	 
	 	By:  	 
	 	 	Name: Richard Palmer
	 	 	Title:   President

 

[Signature page to Ominibus Warrant Amendment]

 

     

     

    

 

	 	EXXONMOBIL RENEWABLES LLC
	 	 	 
	 	By: 	 
	 	 	Name: Gloria Moncada
	 	 	Title:   President

 

[Signature page to Omnibus Warrant Amendment]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]